CXXC5 Antibody [L11K10]

Catalog No.: F7848

Application: Reactivity: Human, Mouse, Rat, Monkey

Lane 1: MCF7, Lane 2: T47D, Lane 3: COS, Lane 4: H-4-II-E

当該製品は品切れ状态で、ごメールアドレスを教えていただければ、在庫があると、メールで顧客様に伝えます。

代表番号: 045-509-1970|電子メール：sales@selleck.co.jp

使用情報

Dilution
WB1:1000 IP1:100 IF1:1000

Application
WB, IP, IF

Source
Rabbit Monoclonal Antibody

Reactivity
Human, Mouse, Rat, Monkey

Storage Buffer
PBS, pH 7.2+50% Glycerol+0.05% BSA+0.01% NaN3

Storage (from the date of receipt)
-20°C (avoid freeze-thaw cycles), 2 years

Predicted MW
33 kDa

Datasheet & SDS

生物学的記述

Specificity
CXXC5 Antibody [L11K10] detects endogenous levels of total CXXC5 protein.

Clone
L11K10

Synonym(s)
CXXC-type zinc finger protein 5; CXXC5

Background
CXXC5 belongs to the CXXC-type zinc finger protein family that recognizes unmethylated CpG dinucleotides and modulates Wnt/β-catenin signaling alongside BMP and TGF-β pathways during development and differentiation. It consists of a central CXXC domain flanked by acidic and proline-rich regions that mediate DNA binding and protein-protein interactions with Dishevelled, Smad3/4, and transcriptional co-regulators. CXXC5 suppresses canonical Wnt signaling by sequestering Dishevelled through direct binding that prevents LRP5/6 phosphorylation and β-catenin stabilization, thereby repressing target gene activation like Runx2 during osteoblast commitment while promoting non-canonical planar cell polarity through selective Dvl2 engagement. CXXC5 facilitates BMP-induced endothelial differentiation by coordinating VEGFR2 transcription via Smad1/5/8 nuclear translocation and enhances TGF-β-mediated apoptosis through Smad3 phosphorylation and Smad4 nuclear import that drives pro-apoptotic gene sets. CXXC5 transcriptionally activates MyoD and myogenin promoters to drive C2C12 myoblast fusion and sarcomere assembly, integrating with retinoic acid signaling for lineage specification. CXXC5 governs myelopoiesis through cytokine-driven maturation of hematopoietic precursors and supports angiogenesis via endothelial migration on VEGF gradients, with peak expression in embryonic mesoderm and adult bone marrow reflecting stage-specific roles in tissue morphogenesis.

Background

CXXC5 belongs to the CXXC-type zinc finger protein family that recognizes unmethylated CpG dinucleotides and modulates Wnt/β-catenin signaling alongside BMP and TGF-β pathways during development and differentiation. It consists of a central CXXC domain flanked by acidic and proline-rich regions that mediate DNA binding and protein-protein interactions with Dishevelled, Smad3/4, and transcriptional co-regulators. CXXC5 suppresses canonical Wnt signaling by sequestering Dishevelled through direct binding that prevents LRP5/6 phosphorylation and β-catenin stabilization, thereby repressing target gene activation like Runx2 during osteoblast commitment while promoting non-canonical planar cell polarity through selective Dvl2 engagement. CXXC5 facilitates BMP-induced endothelial differentiation by coordinating VEGFR2 transcription via Smad1/5/8 nuclear translocation and enhances TGF-β-mediated apoptosis through Smad3 phosphorylation and Smad4 nuclear import that drives pro-apoptotic gene sets. CXXC5 transcriptionally activates MyoD and myogenin promoters to drive C2C12 myoblast fusion and sarcomere assembly, integrating with retinoic acid signaling for lineage specification. CXXC5 governs myelopoiesis through cytokine-driven maturation of hematopoietic precursors and supports angiogenesis via endothelial migration on VEGF gradients, with peak expression in embryonic mesoderm and adult bone marrow reflecting stage-specific roles in tissue morphogenesis.

References
[1] Fang L, et al. Oncol Lett. 2018 Jul;16(1):395-401. [2] Kim HY, et al. Cell Death Differ. 2015 Jun;22(6):912-20.

PVDFメンブレン孔径参考表

Protein Size (kDa)	PVDF Transfer Membrane Pore Size (μm)
< 10	0.22
10-20	0.22
20-30	0.45
30-45	0.45
45-70	0.45
80-100	0.45
100-140	0.45
> 140	0.45

技術サポート

ストックの作り方、阻害剤の保管方法、細胞実験や動物実験の際に注意すべき点など、製品を取扱う時に問い合わせが多かった質問に対しては取扱説明書でお答えしています。

Handling Instructions

他に質問がある場合は、お気軽にお問い合わせください。

* 必須

* 大学・企業名 大学・企業名を記入してください

* 名前 名前を記入してください

* 電子メール 電子メール・アドレスを記入してください 有効なメールアドレスを入力してください

電話番号

* 内容 お問い合わせ内容をご入力ください

Protein Size (kDa)	Separating Gel Percentage
4-40	20%
12-45	15%
10-70	12.5%
15-100	10%
25-100	8%
60-210	5%